The weekly litigation news digest is live. Subscribe now

IP Verse

Dexmedetomidine Premix Formulation - EP2648520

The patent EP2648520 was granted to Hospira on Apr 11, 2018. The application was filed on Jun 18, 2012 under application number EP12823234A. The patent is currently recorded with a legal status of "Revoked".

EP2648520

HOSPIRA
Application Number
EP12823234A
Filing Date
Jun 18, 2012
Status
Revoked
Jan 7, 2022
Publication Date
Apr 11, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
FRESENIUS KABI DEUTSCHLANDJan 9, 2019FRESENIUS KABI DEUTSCHLAND -

Patent Citations (7) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTUS2010094219
INTERNATIONAL-SEARCH-REPORTUS2010305160
INTERNATIONAL-SEARCH-REPORTUS2010326868
INTERNATIONAL-SEARCH-REPORTUS2011269666
INTERNATIONAL-SEARCH-REPORTUS6716867
OPPOSITIONWO2013103378
SEARCHUS6716867

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents